What sleep medication can be added to a regimen of buspirone 5 mg twice daily for a patient whose relative died by suicide three months ago, who wants a stronger nighttime effect and declines counseling?

Buspirone Should NOT Be Increased for Sleep—Add a Guideline-Recommended Hypnotic Instead

Buspirone is not a sleep medication and actually has stimulant properties that worsen insomnia 1, 2. Increasing the nighttime dose will likely make sleep worse, not better. The patient needs a dedicated hypnotic medication added to her regimen.

Critical Safety Consideration: Recent Suicide Loss

This patient experienced a relative's suicide 3 months ago, placing her at elevated risk for suicidal ideation herself. FDA labeling for hypnotics warns of depression and suicidal thoughts/actions, particularly in patients taking sedatives 3. This requires:

• Avoid benzodiazepines and Z-drugs if possible due to their association with psychiatric adverse effects and depression 3
• Close monitoring for mood changes
• Strong reconsideration of the "no counseling" stance—grief counseling is clinically indicated here

Recommended Sleep Medication Options

Based on the 2017 American Academy of Sleep Medicine guidelines 4, the following are evidence-based options:

First-Line Recommendations for Sleep Maintenance:

1. Suvorexant 10-20 mg at bedtime

   • Orexin receptor antagonist with a different mechanism than traditional sedatives
   • Specifically recommended for sleep maintenance insomnia 4
   • May have lower psychiatric risk profile than benzodiazepines

2. Low-dose doxepin 3-6 mg at bedtime

   • Specifically recommended for sleep maintenance insomnia 4
   • Antihistamine effect at low doses without significant antidepressant effects
   • May be particularly appropriate given grief/mood context

3. Eszopiclone 2-3 mg at bedtime

   • Effective for both sleep onset and maintenance 4
   • However, carries warnings about psychiatric effects 3

What NOT to Use:

• Do NOT increase buspirone—it increases sleep latency and decreases total sleep 1, 2
• Trazodone is NOT recommended by guidelines 4
• Diphenhydramine is NOT recommended 4
• Melatonin is NOT recommended for insomnia 4

Practical Implementation

Start with suvorexant 10 mg or doxepin 3 mg at bedtime while maintaining buspirone 5 mg twice daily for anxiety. These have the best safety profiles given her recent trauma exposure.

Key Monitoring Points:

• Assess for emergence of depressive symptoms or suicidal ideation at every visit
• Evaluate sleep improvement within 1-2 weeks
• Watch for next-day sedation (adjust dose if present)
• Avoid grapefruit juice, which significantly increases buspirone levels 5

Critical Pitfall to Avoid

The biggest mistake would be increasing buspirone for sleep. Research clearly demonstrates buspirone has stimulant rather than sedative properties 1, 2. One study showed buspirone increased wake time after sleep onset, particularly on the first night, and increased sleep latency 1. Another found it increased sleep latency and decreased total sleep through reductions in both non-REM and REM sleep 2.

Addressing the "No Counseling" Preference

While respecting patient autonomy, strongly encourage grief counseling or at minimum a mental health evaluation given the suicide loss. The combination of recent family suicide, sleep disturbance, and hypnotic medication use creates a high-risk scenario that medication alone cannot adequately address. Document this discussion and the patient's refusal if she continues to decline.